Group One Trading, L.P. Agios Pharmaceuticals, Inc. Transaction History

Group One Trading, L.P.

$3.01 Billion
Q2 2024

A detailed history of Group One Trading, L.P. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 10,103 shares of AGIO stock, worth $460,696. This represents 0.01% of its overall portfolio holdings.

Number of Shares

10,103

Holding current value

$460,696

% of portfolio

0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$27.55 - $48.83 $278,337 - $493,329	10,103 New	10,103 $435,000
Q4 2023 Feb 14, 2024	SELL	$19.97 - $24.53 $405,391 - $497,959	-20,300 Reduced 95.15%	1,035 $23,000
Q3 2023 Nov 09, 2023	BUY	$24.36 - $28.18 $203,576 - $235,500	8,357 Added 64.39%	21,335 $528,000
Q2 2023 Aug 09, 2023	BUY	$21.38 - $29.19 $159,644 - $217,961	7,467 Added 135.49%	12,978 $367,000
Q1 2023 May 12, 2023	BUY	$21.74 - $30.93 $53,784 - $76,520	2,474 Added 81.46%	5,511 $126,000
Q4 2022 Feb 09, 2023	BUY	$24.81 - $31.52 $28,481 - $36,184	1,148 Added 60.77%	3,037 $85,000
Q3 2022 Nov 09, 2022	SELL	$19.51 - $34.14 $741,984 - $1.3 Million	-38,031 Reduced 95.27%	1,889 $53,000
Q2 2022 Aug 11, 2022	SELL	$17.06 - $31.42 $556,599 - $1.03 Million	-32,626 Reduced 44.97%	39,920 $885,000
Q1 2022 May 12, 2022	BUY	$26.68 - $34.81 $1.94 Million - $2.53 Million	72,546 New	72,546 $2.11 Million
Q4 2021 Feb 11, 2022	SELL	$29.58 - $49.78 $145,356 - $244,618	-4,914 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$41.92 - $58.18 $205,994 - $285,896	4,914 New	4,914 $227,000
Q1 2021 May 12, 2021	SELL	$44.23 - $57.5 $471,536 - $613,007	-10,661 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$33.21 - $46.54 $266,809 - $373,902	8,034 Added 305.82%	10,661 $462,000
Q3 2020 Nov 12, 2020	BUY	$33.87 - $55.93 $88,976 - $146,928	2,627 New	2,627 $92,000
Q2 2020 Aug 13, 2020	SELL	$34.45 - $53.48 $1.23 Million - $1.91 Million	-35,677 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$31.52 - $53.81 $1.12 Million - $1.92 Million	35,677 New	35,677 $1.27 Million
Q4 2019 Feb 10, 2020	SELL	$30.08 - $50.59 $175,306 - $294,838	-5,828 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$32.4 - $49.58 $182,347 - $279,036	5,628 Added 2814.0%	5,828 $189,000
Q2 2019 Aug 09, 2019	SELL	$46.17 - $68.1 $44,507 - $65,648	-964 Reduced 82.82%	200 $10,000
Q1 2019 May 13, 2019	SELL	$45.92 - $67.67 $175,047 - $257,958	-3,812 Reduced 76.61%	1,164 $79,000
Q4 2018 Feb 06, 2019	BUY	$42.73 - $76.53 $212,624 - $380,813	4,976 New	4,976 $229,000
Q2 2018 Aug 14, 2018	SELL	$73.22 - $99.55 $216,072 - $293,772	-2,951 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$59.83 - $86.53 $1.51 Million - $2.19 Million	-25,271 Reduced 89.54%	2,951 $241,000
Q4 2017 Feb 09, 2018	BUY	$52.12 - $72.33 $269,304 - $373,729	5,167 Added 22.41%	28,222 $1.61 Million
Q3 2017 Nov 15, 2017	BUY	$54.89 - $67.12 $64,111 - $78,396	1,168 Added 5.34%	23,055 $1.54 Million
Q2 2017 Aug 14, 2017	BUY	N/A	21,887	21,887 $1.13 Million

Others Institutions Holding AGIO

# of Institutions

226

Shares Held

56.3M

Call Options Held

275K

Put Options Held

251K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.5B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Agios Pharmaceuticals, Inc. Transaction History